✦ LIBER ✦

Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial

✍ Scribed by JL Mega; E Braunwald; S Mohanavelu; P Burton; R Poulter; F Misselwitz; V Hricak; ES Barnathan; P Bordes; A Witkowski; V Markov; L Oppenheimer; CM Gibson

Book ID: 117304743
Publisher: The Lancet
Year: 2009
Tongue: English
Weight: 268 KB
Volume: 374
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(09)60738-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rivaroxaban versus placebo in patients w

Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial

✍ JL Mega; E Braunwald; S Mohanavelu; P Burton; R Poulter; F Misselwitz; V Hricak; 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 268 KB

Autoantibodies to phosphorylcholine and

Autoantibodies to phosphorylcholine and cardiovascular outcomes in patients with acute coronary syndromes in the ATLAS ACS-TIMI 46 trial

✍ Bram J. Geller, Jessica L. Mega, David A. Morrow… 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 299 KB

Otamixaban for the treatment of patients

Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial

✍ Marc S Sabatine; Elliott M Antman; Petr Widimsky; Iftikhar O Ebrahim; Robert G K 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 247 KB

The effects of topical heat therapy on c

The effects of topical heat therapy on chest pain in patients with acute coronary syndrome: a randomised double-blind placebo-controlled clinical trial

✍ Mohammadpour, Ali; Mohammadian, Batol; Basiri Moghadam, Mehdi; Nematollahi, Mahm 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

Rationale and design of the Anti-Xa Ther

Rationale and design of the Anti-Xa Therapy to Lower cardiovascular events in Addition to standard therapy in Subjects with Acute Coronary Syndrome–Thrombolysis in Myocardial Infarction 51 (ATLAS-ACS 2 TIMI 51) trial: A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome

✍ C. Michael Gibson; Jessica L. Mega; Paul Burton; Shinya Goto; Freek Verheugt; Ch 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 428 KB

Efficacy of Ranolazine in Patients With

Efficacy of Ranolazine in Patients With Chronic Angina: Observations From the Randomized, Double-Blind, Placebo-Controlled MERLIN–TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non–ST-Segment Elevation Acute Coronary Syndromes) 36 Trial

✍ Sean R. Wilson; Benjamin M. Scirica; Eugene Braunwald; Sabina A. Murphy; Ewa Kar 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 300 KB